Pharmaceutical Manufacturing Market Size to Record US$ 2,102.5 Bn through 2030
The global Pharmaceutical Manufacturing market size is expected to be worth around US$ 2,102.5 billion by 2030, according to a new report by Vision Research Reports.
The global Pharmaceutical Manufacturing market size was valued at US$ 505.52 billion in 2020 and is anticipated to grow at a CAGR of 21.34% during forecast period 2020 to 2030.
Continuous investments made by the pharmaceutical and outsourcing firms to expand their manufacturing facilities have positively impacted market growth. For instance, in February 2020, AstraZeneca invested USD 132 million to expand its Australian manufacturing site. Similarly, in December 2020, a global outsourcing solution provider, PCI Pharma Services, expanded its U.K.-based Tredegar facility to improve its high potent drug development and manufacturing capabilities. The emergence of new management systems, such as enterprise resource planning systems and manufacturing execution systems has optimized the data management process.
Growth Factors
The pharmaceutical firms have implemented cloud technology to increase operational efficiency across R&D and manufacturing processes. Thus, the implementation of cloud technology and is expected to drive the market.
Longer life expectancies and a rise in the geriatric population has spurred the demand for pharmaceutical products to treat several chronic disorders. These factors have also prompted many individuals to use medications to improve the quality of life and wellness, globally. In addition, the emergence of new pandemics, viruses, and drug-resistant infections has provided potential avenues to pharmaceutical manufacturers to accelerate their drug production.
Report Highlights
Key Players
Market Segmentation
Pharmaceutical Manufacturing Drug Development Type Outlook
Pharmaceutical Manufacturing Formulation Outlook
Pharmaceutical Manufacturing Route of Administration Outlook
Pharmaceutical Manufacturing Therapy Area Outlook
Pharmaceutical Manufacturing Prescription Outlook
Pharmaceutical Manufacturing Age Group Outlook
Pharmaceutical Manufacturing Distribution Channel Outlook
Pharmaceutical Manufacturing Regional Outlook
The Pharmaceutical Manufacturing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Pharmaceutical Manufacturing market for the base year 2020 and the forecast between 2020 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Pharmaceutical Manufacturing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Manufacturing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Pharmaceutical Manufacturing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Pharmaceutical Manufacturing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Pharmaceutical Manufacturing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Pharmaceutical Manufacturing market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Pharmaceutical Manufacturing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Pharmaceutical Manufacturing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Pharmaceutical Manufacturing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Pharmaceutical Manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Pharmaceutical Manufacturing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Pharmaceutical Manufacturing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Pharmaceutical Manufacturing market. These factors have benefited the growth of the global market for Pharmaceutical Manufacturing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Pharmaceutical Manufacturing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Pharmaceutical Manufacturing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Pharmaceutical Manufacturing Market, By Drug Development Type
7.1. Pharmaceutical Manufacturing Market, by Drug Development Type, 2020-2030
7.1.1. Outsource
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. In-house
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Pharmaceutical Manufacturing Market, By Formulation
8.1. Pharmaceutical Manufacturing Market, by Formulation, 2020-2030
8.1.1. Tablets
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Capsules
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Injectable
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Sprays
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Suspensions
8.1.5.1. Market Revenue and Forecast (2016-2030)
8.1.6. Powders
8.1.6.1. Market Revenue and Forecast (2016-2030)
8.1.7. Other Formulations
8.1.7.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Pharmaceutical Manufacturing Market, By Route of Administration
9.1. Pharmaceutical Manufacturing Market, by Route of Administration, 2020-2030
9.1.1. Oral
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Topical
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Parenteral
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Inhalations
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Other Routes of Administration
9.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Pharmaceutical Manufacturing Market, By Therapy Area
10.1. Pharmaceutical Manufacturing Market, by Therapy Area, 2020-2030
10.1.1. Cardiovascular Diseases
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Pain
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Diabetes
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Cancer
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Respiratory Diseases
10.1.5.1. Market Revenue and Forecast (2016-2030)
10.1.6. Other Diseases
10.1.6.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Pharmaceutical Manufacturing Market, By Prescription
11.1. Pharmaceutical Manufacturing Market, by Prescription, 2020-2030
11.1.1. Prescription Medicines
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Over-the-counter (OTC) Medicines
11.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global Pharmaceutical Manufacturing Market, By Age Group
12.1. Pharmaceutical Manufacturing Market, by Age Group, 2020-2030
12.1.1. Children & Adolescents
12.1.1.1. Market Revenue and Forecast (2016-2030)
12.1.2. Adults
12.1.2.1. Market Revenue and Forecast (2016-2030)
12.1.3. Geriatric
12.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 13. Global Pharmaceutical Manufacturing Market, By Distribution Channel
13.1. Pharmaceutical Manufacturing Market, by Distribution Channel, 2020-2030
13.1.1. Retail
13.1.1.1. Market Revenue and Forecast (2016-2030)
13.1.2. Non-retail
13.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 14. Global Pharmaceutical Manufacturing Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.1.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.1.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.1.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.1.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.1.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.1.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.1.8.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.1.8.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.1.8.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.1.8.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.1.8.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.1.8.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.1.9.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.1.9.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.1.9.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.1.9.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.1.9.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.1.9.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.2.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.2.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.2.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.2.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.2.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.2.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.2.8.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.2.8.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.2.8.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.2.8.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.2.8.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.2.8.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.2.9.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.2.9.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.2.9.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.2.9.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.2.9.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.2.9.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.2.10.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.2.10.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.2.10.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.2.10.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.2.10.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.2.10.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.2.11.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.2.11.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.2.11.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.2.11.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.2.11.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.2.11.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.3.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.3.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.3.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.3.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.3.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.3.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.3.8.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.3.8.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.3.8.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.3.8.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.3.8.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.3.8.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.3.9.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.3.9.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.3.9.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.3.9.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.3.9.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.3.9.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.3.10.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.3.10.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.3.10.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.3.10.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.3.10.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.3.10.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.3.11.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.3.11.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.3.11.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.3.11.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.3.11.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.3.11.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.4.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.4.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.4.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.4.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.4.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.4.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.4.8.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.4.8.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.4.8.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.4.8.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.4.8.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.4.8.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.4.9.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.4.9.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.4.9.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.4.9.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.4.9.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.4.9.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.4.10.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.4.10.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.4.10.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.4.10.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.4.10.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.4.10.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.4.11.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.4.11.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.4.11.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.4.11.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.4.11.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.4.11.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.5.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.5.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.5.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.5.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.5.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.5.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.5.8.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.5.8.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.5.8.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.5.8.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.5.8.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.5.8.7. Market Revenue and Forecast, by Age Group (2016-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Drug Development Type (2016-2030)
14.5.9.2. Market Revenue and Forecast, by Formulation (2016-2030)
14.5.9.3. Market Revenue and Forecast, by Route of Administration (2016-2030)
14.5.9.4. Market Revenue and Forecast, by Therapy Area (2016-2030)
14.5.9.5. Market Revenue and Forecast, by Prescription (2016-2030)
14.5.9.6. Market Revenue and Forecast, by Distribution Channel (2016-2030)
14.5.9.7. Market Revenue and Forecast, by Age Group (2016-2030)
Chapter 15. Company Profiles
15.1. F. Hoffmann-La Roche Ltd
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Novartis AG
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. GlaxoSmithKline plc
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Pfizer, Inc.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. AstraZeneca
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Merck & Co., Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Johnson & Johnson
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Sanofi SA
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Eli Lilly and Company
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Lonza
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers